-transparent.png){kind=logo}
In 50 patients suffering from local cerebral circulation disturbances the effects of bencyclan--administered intravenously in a dosis of 500 mg per day--were evaluated under double-blind conditions. At the same time all patients received digitalis and physiotherapy. Besides a detailed recording of the neurological and psychopathological status a number of psychological tests were applied in order to get objective data about psychomotor function, cerebro-organic capacity and mood. The control recordings after a three weeks' treatment demonstrated an improvement of the clinical as well as the psychological parameters in either group. There were no marked, statistically significant differences in the extent of improvement between the bencyclan and the placebo group; that means bencyclan has no effect on the signs of ischaemic cerebrovascular disease, which exceeds the effects of digitalis and physiotherapy.
E Schneider, and
P A Fischer, and
P Jacobi
May 1975,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
E Schneider, and
P A Fischer, and
P Jacobi
April 1974,
Annals of clinical research,
E Schneider, and
P A Fischer, and
P Jacobi
October 1971,
Munchener medizinische Wochenschrift (1950),
E Schneider, and
P A Fischer, and
P Jacobi
May 1974,
Klinische Wochenschrift,
E Schneider, and
P A Fischer, and
P Jacobi
October 1981,
Fortschritte der Neurologie-Psychiatrie,
E Schneider, and
P A Fischer, and
P Jacobi
March 1976,
Lijecnicki vjesnik,
E Schneider, and
P A Fischer, and
P Jacobi
July 1975,
Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie,
E Schneider, and
P A Fischer, and
P Jacobi
January 1981,
La Nouvelle presse medicale,
E Schneider, and
P A Fischer, and
P Jacobi
January 1980,
Der Nervenarzt,
E Schneider, and
P A Fischer, and
P Jacobi
January 1974,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
